Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| Aug 12 | SUPN | Supernus Pharmaceuticals,… | MEXER | 750 | — | — | +5.5% | Open the original filing on SEC.gov |
| Jul 29 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 750 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 1,250 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | FTAX | 675 | $50.69 | $34.2K | -4.8% | Open the original filing on SEC.gov |
| Feb 25 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 1,250 | — | — | +9.8% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 1,250 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 750 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 1,125 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 671 | — | — | -5.0% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 1,250 | — | — | +10.3% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 369 | $50.86 | $18.8K | -2.9% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 750 | — | — | +6.3% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | FTAX | 603 | $51.35 | $31K | -4.9% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 1,125 | — | — | +10.0% | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 13,500 | — | — | — | Open the original filing on SEC.gov |
| Sep 25, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 1,875 | — | — | — | Open the original filing on SEC.gov |
| Sep 25, 2025 | SUPN | Supernus Pharmaceuticals,… | FTAX | 840 | $46.21 | $38.8K | -7.1% | Open the original filing on SEC.gov |
| Sep 25, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER | 1,875 | — | — | +18.8% | Open the original filing on SEC.gov |
| Sep 10, 2025 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 1,875 | — | — | — | Open the original filing on SEC.gov |